Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer

Medicine, Hepatobiliary System, Oncology, Life Sciences, Cell Biology, Biochemistry,
Pancreatic Cancer   KRAS   Resistance   Oncogenes   Cancer Research  

Mechanisms of Resistance to Carcinogenic KRAS Inhibition in Pancreatic Cancer Background Pancreatic Ductal Adenocarcinoma (PDAC) is a highly lethal disease. Most patients are diagnosed at an advanced stage and typically die within 12 months, primarily due to limited treatment options and poor response to standard chemotherapy. KRAS is the most crit...

Resistance, Rebound, and Recurrence Regrowth Patterns in Pediatric Low-Grade Glioma Treated by MAPK Inhibition: A Modified Delphi Approach to Build International Consensus

Medicine, Pediatrics, Neurology, Neurosurgery, Oncology,
Pediatric   Low-Grade Glioma   MAPK Inhibition   Resistance   Recurrence   Rebound   Delphi Method  

International Consensus on Resistance, Rebound, and Recurrence in Pediatric Low-Grade Glioma with MAPK Inhibition Therapy: Established Using a Modified Delphi Method Academic Background Pediatric low-grade glioma (PLGG) is the most common type of tumor in the central nervous system of children. Although these tumors have a relatively high overall s...